Validation of the Portuguese MDS-UPDRS: Challenges to Obtain a Scale Applicable to Different Linguistic Cultures
Tiago Soares,Thiago Cardoso Vale,Leonor Correia Guedes,Ricardo Oliveira Maciel,Ana Patrícia Antunes,Sarah Camargos,Anabela Valadas,Miguel Coelho,Catarina Godinho,Débora Maia,Patrícia Lobo,Raphael Maia,Tiago Teodoro,Carlos Rieder,Ana Graça Velon,Maria José Rosas,Ana Calado,Verónica Caniça,José Vale,Alexandre Mendes,Ana Margarida Rodrigues,Maria Manuela Costa,Tânia Lampreia,Henrique B Ferraz,Vitor Tumas,Egberto Barbosa,Glenn T Stebbins,Barbara C Tilley,Sheng Luo,Nancy R LaPelle,Christopher G Goetz,Francisco Cardoso,Joaquim J Ferreira,MDS‐UPDRS Portuguese Validation Study Group
DOI: https://doi.org/10.1002/mdc3.14236
2024-10-26
Abstract:Background: The MDS-UPDRS has been available in English since 2008, showing satisfactory clinimetric results and being proposed as the new official benchmark scale for Parkinson's disease (PD), being cited as a core instrument for PD in the National Institutes of Neurological Disorders and Stroke Common Data Elements program. For this reason, the MDS created guidelines for development of MDS-UPDRS official, clinimetrically validated translations. Objective: This study presents the formal process used to obtain the officially approved Portuguese version of the MDS-UPDRS. Methods: The study consisted of three phases: (1) Independent translation by Portuguese and Brazilian teams followed by a challenging consensus process that this article particularly emphasizes; (2) Cognitive pretest involving raters and patients from both Portugal and Brazil; (3) Validation test with a sample of 367 native Portuguese-speaking PD patients. Results: The overall factor structure of the Portuguese version was consistent with the English version based on a comparative fit index ≥0.96 for all four parts of the MDS-UPDRS. Conclusion: This version can be designated as the official Portuguese version of the MDS-UPDRS.